NDRS approach to understanding rare disease and cancer at a population level.

TOPICS COVERED

Presentations by leading specialists in the field of Histiocytosis to include:

• Haemophagocytic Lymphohistiocytosis (HLH) Langerhans Cell Histiocytosis (LCH)
• Juvenile xanthogranuloma (JXG)
• Rosai-Dorfman Disease (RD)
• Erdheim-Chester disease (ECD)
• Abstract Presentations

Call for Abstracts OPEN Please contact [email protected] for Guidelines.
https://app.oxfordabstracts.com/stages/2984/submitter

WHO SHOULD ATTEND?

• Clinicians
• Consultants
• Trainees and Researchers
• GP's Patients
• Parents of Histiocytic disorders.

Those interested in development and knowledge transfer of theses rare disorders.

SPEAKERS

• Dr. Eli Diamond - Member of the interdisciplinary team at Memorial Sloan Kettering treating and studying patients with histiocytic disorders such as Erdheim-Chester disease and Langerhans cell histiocytosis. Clinical Expertise - Neuro-Oncology; Adult Brain Tumours; Histiocytosis.
• Dr. Rebecca Marsh – Member of the paediatric haematologist-oncologist team affiliated with Cincinnati Children's Hospital Medical Center.
• Dr Mark Bishton - Consultant Haematologist, Nottinghamshire University Hospitals Trust:
• Hanhua Liu - Senior Cancer Intelligence Analyst, Public Health England;
• Peter Stilwell - Senior Data Analyst, Public Health England.

Representatives of the HiHASC HLH Across Speciality Collaboration.
Hosted by: Prof. M. Collin and Dr. C. Booth

For more information, please contact: [email protected]